Bill Text: NY A07379 | 2019-2020 | General Assembly | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft

---

Bill Title: Requires the labeling of prescription drug containers where such drugs contain gluten, lactose or food dye.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2020-01-08 - referred to higher education [A07379 Detail]

Download: New_York-2019-A07379-Introduced.html

---

                STATE OF NEW YORK
        ________________________________________________________________________
                                          7379
                               2019-2020 Regular Sessions
                   IN ASSEMBLY
                                     April 29, 2019
                                       ___________
        Introduced  by  M.  of  A.  BRAUNSTEIN  -- read once and referred to the
          Committee on Higher Education
        AN  ACT  to  amend  the  education  law,  in  relation  to  labeling  of
          prescription drugs containing gluten, lactose or food dye
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
     1    Section 1. Subdivision 2 of section 6811-a of the  education  law,  as
     2  amended  by  section  9  of part D of chapter 60 of the laws of 2014, is
     3  amended to read as follows:
     4    2. Except as otherwise  authorized  in  the  Federal  Food,  Drug  and
     5  Cosmetic  Act,  no  drug  for  which any prescription is required by the
     6  provisions of the Federal Food, Drug and Cosmetic Act or by the  commis-
     7  sioner  of  health  contained  within  a  bottle,  vial, carton or other
     8  container, or in any way affixed or appended to  or  enclosed  within  a
     9  package  of  any  kind,  and  designed  or intended for delivery in such
    10  container or package to an ultimate consumer, shall be  manufactured  or
    11  distributed  within  this  state  unless  such  container or package has
    12  clearly and permanently marked or imprinted upon it in conformance  with
    13  the applicable plan required by subdivision three of this section:
    14    (a)  an  individual  symbol,  N.  D.  C. number, company name, number,
    15  letters, words or marking identifying the manufacturer or distributor of
    16  the drug;
    17    (b) an N. D. C. number, symbol,  number,  letters,  words  or  marking
    18  identifying such drug or combination of drugs;
    19    (c)  where a prescription drug product contains any active or inactive
    20  ingredient made  from  any  gluten-containing  grain,  including  wheat,
    21  barley,  rye,  or  any  crossbred    hybrid  of  such grains, or where a
    22  prescription drug product contains any  active  or  inactive  ingredient
    23  containing  lactose,  or where a prescription drug product contains food
    24  dye, such ingredients shall appear on the label in words clearly identi-
    25  fying each; and
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD10881-02-9
        A. 7379                             2
     1    [(c)] (d) whenever the distributor of the  prescription  drug  product
     2  does  not  also manufacture the product the names and places of business
     3  of both shall appear on the label in words clearly distinguishing each.
     4    § 2. This act shall take effect immediately.